肺结核TNF家族的预测价值:对多个数据集的综合因果效应分析
Wenxiu Mo1, Zhezhe Cui2, Jingming Zhao2
1School of Public Health and Management, Youjiang Medical University for Nationalities, Baise, China.
Frontiers in immunology
|June 5, 2024
概括
这项研究确定了关键的炎症蛋白质 - - 淋巴毒素-α (LT) 和TNFRSF9 - - 作为对肺结核 (PTB) 的保护因素. 升高的IL20Ra可能会增加PTB风险,这表明潜在的预测标志物.
科学领域:
- 免疫学 免疫学 免疫学
- 遗传学 是一个遗传学.
- 流行病学 流行病学
背景情况:
- 肺结核 (PTB) 研究缺乏强有力的因果证据,将其与炎症因素联系起来.
- 了解跨种族的PTB多样化的炎症和免疫机制至关重要.
研究的目的:
- 在不同的人群中识别与PTB易感性相关的炎症蛋白质.
- 阐明不同种族的PTB中各种炎症和免疫反应.
主要方法:
- 在GWAS数据上使用了两样本的门德尔随机化 (MR) 研究与反向差异加权 (IVW).
- 分析了来自欧洲和东亚人口的14824个人的91个人类炎症蛋白.
- 采用了局部化和元分析来证实因果关系和结合效应.
主要成果:
- 淋巴毒素-α (LT) 和TNFRSF9与PTB有显著的负相关性,表明它们具有保护作用.
- 介素-20受体亚单元α (IL20Ra) 呈现出显著的正相关性,表明PTB风险增加.
- 局部化分析发现LT和PTBSNP之间没有共同的因果变异;元分析证实了LT,TNFRSF9和IL20Ra在东亚人的联合作用.
结论:
- 特定的炎症蛋白水平,特别是LT和TNFRSF9,对于PTB免疫反应至关重要.
- 改变的LT和TNFRSF9水平可以作为PTB发展的预测标记.
- 需要进一步的临床验证来确认这些炎症蛋白对PTB的影响.
相关概念视频
Pulmonary Tuberculosis IV
134
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
134
Pulmonary Tuberculosis III
322
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
322
Pulmonary Tuberculosis I
231
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
231
Pulmonary Tuberculosis V
177
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
177
Pulmonary Tuberculosis II
217
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
217
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
130
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
130


